

Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation
David Brühlmann - CMC Development Leader, Biotech C-level Advisor, Business Strategist
The Go-to Podcast for Biotech Scientists Who Want to Master Biopharma CMC Development and Biomanufacturing.**TOP 10 LIFE SCIENCES PODCAST**Are you ready to simplify bioprocess development and scale with confidence to reduce time to market?Are you feeling overwhelmed by the complexity and guesswork of biologics development and biomanufacturing?Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commercialization?There's a way to simplify and streamline so you can remove complexity, skip trials and errors, deliver your groundbreaking therapy to clinics and market without delay, and still enjoy every single step.I'm David Brühlmann, a biotech entrepreneur and strategic advisor who partners with C-level biopharma leaders to tackle one of our industry's biggest challenges: reducing manufacturing costs to make lifesaving therapies accessible to more patients worldwide.Through engaging conversations with industry pioneers and practical insights from the trenches, this podcast tackles the critical challenges in bioprocess CMC development and manufacturing of recombinant proteins and cell and gene therapy products. We cut through the complexity so you can:Master bioprocess development with confidence and clarityExcel at scale-up and manufacturing of biologicsTransform your innovative therapy and manufacturing technology into market-ready solutions fasterOptimize manufacturing costs without compromising qualityMake data-driven decisions that reduce the risk of failureI can’t wait to help you do biotech the smart way.Grab a cup of coffee and your favorite notebook and pen. Now is the time to take your bioprocessing game to the next level.Ready to transform your biomanufacturing journey? Let's dive in!Next Steps:Book a free call to reduce biomanufacturing costs and make lifesaving therapies more accessible: https://bruehlmann-consulting.com/call🧬 Ready to accelerate your IND timeline? Get the proven CMC Dashboard that's guided successful mAb programs from chaos to submission: https://stan.store/SmartBiotech/p/cmc-dashboard-for-biotech-foundersAccelerate biologics development with expert guidance: https://bruehlmann-consulting.comFor sponsorship opportunities, contact us at hello@bruehlmann-consulting.comVisit the Website: https://smartbiotechscientist.comEmail us: hello@bruehlmann-consulting.com
Episodes
Mentioned books

Mar 26, 2024 • 26min
39: Balancing Perfusion Process Development and Sustainability w/ Jochen Sieck - Part 1
Explore perfusion processes and sustainability with our guest, Jochen Sieck, Director of Cell Culture Media and Process Development at Merck Life Science.Learn about the evolution of perfusion methodologies, its historical roots in addressing product stability, and its recent return to continuous and integrated manufacturing.Jochen discusses the economic and strategic reasons behind perfusion's resurgence, emphasizing the need for flexible, smaller-scale facilities.Key Learnings:Gain insight into the environmental impact of traditional facilities and the potential benefits of alternatives.Dive deep into the balance of cost, productivity, and sustainability in media consumption.Discover strategies for optimizing perfusion rates and sustainability.Get ready to expand your understanding of perfusion processes, sustainability, and the delicate dance between economics and environmental consciousness.Connect with Jochen Sieck:LinkedIn: https://www.linkedin.com/in/jochenbsieckACTIP Fellowship award: https://www.actip.org/fellowshipResources:Perfusion Cell Culture Processes for Biopharmaceuticals by Moritz Wolf, Jean-Marc Bielser, and Massimo Morbidelli: https://www.cambridge.org/core/books/perfusion-cell-culture-processes-for-biopharmaceuticals/5C650AD26D52B2435E7796D382ECE5DANext Step:Elevate your biologics development strategy — Schedule your free assessment now: https://bruehlmann-consulting.com🧬 Stop second-guessing your CMC strategy. Get an investor-ready CMC roadmap in 2 weeks, before mistakes cost you $2M+ and 18 months of delays. Secure your spot here.Support the show

Mar 21, 2024 • 17min
38: How to Master Downstream: A Deep Dive Into Bioprocessing Purification w/ Wei Zhang - Part 2
In part 2 of this insightful episode, we embark on a journey into the intricate world of biotech purification processes. Our guest, Wei Zhang, DSP Group Head at A*STAR Bioprocessing Technology Institute, delves into three key modalities, shedding light on the challenges and advancements in virus, RNA, and traditional vaccine purification.You will learn:Learn how to master the purification of virusesGet an overview of the advancements in RNA purification techniques: the evolution from simple RNA structures to long-stranded messenger RNA (mRNA)How to improve separation efficiency and simplify scale-up to meet increasing demandsTune in as we unravel the complexities of downstream processing and glean valuable insights to excel in the dynamic field of bioprocessing purification.Connect with Wei Zhang:LinkedIn: https://www.linkedin.com/in/wei-zhang-a6539845Next Step:Elevate your bioprocess development capabilities — Schedule your free assessment now: https://bruehlmann-consulting.comSupport the show

Mar 19, 2024 • 20min
37: How to Master Downstream: A Deep Dive Into Bioprocessing Purification w/ Wei Zhang - Part 1
In this episode, Wei Zhang, DSP Group Head at A*STAR Bioprocessing Technology Institute, delves into the complexities of purification. Wei’s team pioneers bioprocessing processes for diverse biotherapeutics.You will gain valuable insights into the intricate challenges and innovative solutions in bioprocessing purification.You will learn:Master scale-up challengesUnderstand how you can ensure product stabilityGet an overview of the advancements in purification techniquesThe conversation unravels the evolving landscape of bioprocessing, where the emergence of complex drug modalities necessitates continuous advancements in purification techniques and tools.Connect with Wei Zhang:LinkedIn: https://www.linkedin.com/in/wei-zhang-a6539845Next Step:Elevate your bioprocess development capabilities — Schedule your free assessment now: https://bruehlmann-consulting.comSupport the show

Mar 14, 2024 • 18min
36: Smart Biotech Development Strategies for Adherent Cell Culture w/ Joel Eichmann - Part 2
Welcome back to the second part of our insightful interview with Joel Eichmann, Managing Director of Green Elephant Biotech.In this episode, we delve deeper into the technical aspects of adherent cell expansion systems, explore sustainable biotech practices, and discuss key considerations for cost-efficient and environmentally friendly bioprocessing.Key Insights:How to adopt a strategic approach to adherent cell culture developmentDelve into the intricacies of scaling up adherent cell culture, understanding the challenges associated with transitioning from T-flasks to larger, dynamic environmentsDiscover sustainable biotech practices to reducing your carbon footprintWhether you're a seasoned professional or a curious enthusiast, this episode provides a wealth of knowledge for those passionate about advancing biotech process develoment.Contact Joel Eichmann:LinkedIn: https://www.linkedin.com/in/joel-eichmannWebsite: https://www.greenelephantbiotech.comNext Step:Elevate your biologics development strategy — Schedule your free assessment now: https://bruehlmann-consulting.comSupport the show

Mar 12, 2024 • 19min
35: Smart Biotech Development Strategies for Adherent Cell Culture w/ Joel Eichmann - Part 1
Get ready for a deep dive into the world of bioprocess development as Joel Eichmann, Managing Director of Green Elephant Biotech, shares his expertise on smart strategies for adherent cell culture .Join us as we unravel the intricacies of adherent cell culture and discover the innovative strategies shaping the future of bioprocess development.You’ll get:Acquire a comprehensive understanding of the key challenges in developing an adherent cell culture process.Gain a fresh perspective on the role of microcarriers and explore alternative options for adherent cell cultures.Uncover the unique inspiration behind Joel's bioreactor for adherent cells and how childhood experiences can spark groundbreaking ideas.Join us for an insightful conversation and invaluable insights for biotech professionals, researchers, and enthusiasts like you looking to navigate the complexities of adherent cell culture and bioprocess development.Contact Joel Eichmann:LinkedIn: https://www.linkedin.com/in/joel-eichmannWebsite: https://www.greenelephantbiotech.comNext Step:Elevate your biologics development strategy — Schedule your free assessment now: https://bruehlmann-consulting.comSupport the show

Mar 7, 2024 • 11min
34: The 7 Habits of Highly Successful Innovators - Part 2
Uncover the secrets of successful innovators, including Steve Jobs, Elon Musk, and Thomas Edison, in this enlightening episode of our podcast. We dive deep into the habits that set these trailblazers apart and fuel their innovative spirit.Key learnings include:The power of curiosity and how it leads to groundbreaking ideas and improvements.The importance of connecting the dots to gain new insights and see invisible relationships.The role of risk-taking in pushing boundaries and experimenting with new ideas.These insights provide a roadmap to developing your own innovative mindset and achieving success. Don't miss out on these valuable insights that could ignite your innovative spirit. Tune in now!Next Step:Elevate your biologics development strategy — Grab your free assessment now: https://bruehlmann-consulting.comSupport the show

Mar 5, 2024 • 11min
33: The 7 Habits of Highly Successful Innovators - Part 1
Uncover the secrets of successful innovators, including Steve Jobs, Elon Musk, and Thomas Edison, in this enlightening episode of our podcast. We dive deep into the habits that set these trailblazers apart and fuel their innovative spirit.Key learnings include:The power of curiosity and how it leads to groundbreaking ideas and improvements.The importance of connecting the dots to gain new insights and see invisible relationships.The role of risk-taking in pushing boundaries and experimenting with new ideas.These insights provide a roadmap to developing your own innovative mindset and achieving success. Don't miss out on these valuable insights that could ignite your innovative spirit. Tune in now!Next Step:Elevate your biologics development strategy — Grab your free assessment now: https://bruehlmann-consulting.comSupport the show

Feb 29, 2024 • 17min
32: The Future of Glycoengineering: Trends Unveiled w/ Thomas Rexer - Part 2
Discover the hurdles and breakthroughs in glycoengineering, including the high costs of activated sugars.Thomas Rexer, CTO of eversyn, a spin-off of the Max Planck Institute Magdeburg, unveils eversyn's multi-step biocatalysis process, designed to significantly drive down costs and make in vitro glycoengineering more accessible on a large scale.Key Insights:Uncover the power of multistep biocatalysis in driving down costs and making in vitro glycoengineering more accessible.Bridge the Gap between academia and industry in glycoengineering and thus ensure a smoother integration of groundbreaking glycoengineering technologies into the industrial landscape.Gain valuable insights into the challenges and triumphs of transitioning from pure science to entrepreneurship, offering aspiring scientists a roadmap to navigate the unknown.Connect with Thomas Rexer:LinkedIn: https://www.linkedin.com/in/thomas-rexerWebsite: www.eversyn.deNext Step:Elevate your bioprocess development strategy — Grab your free assessment now: https://bruehlmann-consulting.comSupport the show

Feb 27, 2024 • 18min
31: The Future of Glycoengineering: Trends Unveiled w/ Thomas Rexer - Part 1
Get ready for a crash course in glycoengineering as Thomas Rexer, CTO of eversyn, a spin-off of the Max Planck Institute Magdeburg, breaks down the significance of modifying glycans in biopharmaceuticals.Explore the science behind glycoengineering and its potential to enhance the properties of therapeutic proteins.Key Insights:Unlock new frontiers in glycoengineeringExplore the potential of glycoengineering to revolutionize biopharmaceuticalsEnsure seamless integration of glycoengineering into production processesDon't miss this episode as Thomas unveils the trends that will shape the future of glycoengineering, offering actionable insights for scientists, entrepreneurs, and biotech enthusiasts alike.Connect with Thomas Rexer:LinkedIn: https://www.linkedin.com/in/thomas-rexerWebsite: www.eversyn.deNext Step:Elevate your bioprocess development strategy — Grab your free assessment now: https://bruehlmann-consulting.comSupport the show

Feb 22, 2024 • 15min
30: From Monoclonals to Gene Therapy: Tips for Biopharma Process Development w/ Neil Templeton - Part 2
In our insightful second part of the conversation, we broaden our perspective to delve into the various modalities within the biotech industry, highlighting the unique and shared aspects of process development and scale-up.Neil Templeton, the Director of Upstream Process Development at Solid Biosciences, passionately articulates his commitment towards making gene therapy more accessible. He does this by outlining strategic solutions to reduce the costs of development and manufacturing.You will gain:A comprehensive understanding of process development's similarities and differences across biologics, vaccines, and cell and gene therapy manufacturing.Effective strategies aimed at reducing the costs associated with gene therapy development and manufacturing.Insights into how capitalizing on the expertise from the biologics sector can positively impact other fields.To connect with Neil Templeton and learn more about his work, visit his LinkedIn profile.LinkedIn: https://www.linkedin.com/in/neil-templetonNext Step:Elevate your bioprocess development strategy — Grab your free assessment now: https://bruehlmann-consulting.comSupport the show


